Skip to main content
SyntekaBio,Inc. logo

SyntekaBio,Inc. — Investor Relations & Filings

Ticker · 226330 ISIN · KR7226330009 KO Professional, scientific and technical activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2025-07-15 Regulatory Filings
Country KR South Korea
Listing KO 226330

About SyntekaBio,Inc.

https://www.syntekabio.com/

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure, the AI Bio-Supercom Center, to accelerate pharmaceutical development. The company's core technology, the DeepMatcher® platform, underpins a suite of services for discovering small molecules, antibodies, and neoantigens for personalized cancer vaccines. A key offering is LaunchPad, a factory-like system that continuously generates a stream of 'off-the-shelf' drug candidates for numerous disease targets, aiming to expedite the path to IND-enabling studies. SyntekaBio delivers its solutions through comprehensive discovery partnerships and a modular, cloud-based Software as a Service (SaaS) platform, STB CLOUD, providing researchers with automated tools for drug development and genomics analysis.

Recent filings

Filing Released Lang Actions
본점소재지변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement regarding a change in the company's headquarters location (본점소재지변경). It does not fit into specific categories like financial reports, dividends, or share transactions. As it is a general corporate regulatory announcement that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-07-15 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the amendment of a contract end date and provides specific financial terms of the supply agreement. Since this is a specific regulatory disclosure regarding a commercial contract update and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general Regulatory Filing (RNS).
2025-07-10 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a change in the contract end date and provides updated terms for a supply agreement with Kymera Therapeutics. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into the other specialized categories like M&A or Share Issues, it falls under the general regulatory filing category.
2025-07-10 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Syntekabio regarding a correction (amendment) to a previously disclosed sales and supply contract. It details changes to the contract end date and provides updated terms for a conditional contract. Since this is a specific regulatory disclosure regarding a material contract update and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-05-21 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day and NDR). It provides details such as the date, location, target audience, and purpose of the meetings. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or reports, it is classified as a general regulatory filing/announcement.
2025-05-16 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'SyntekaBio' covering the period from 2025.01.01 to 2025.03.31. It contains detailed corporate information, financial history, capital changes, and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-13 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.